CE vs FOLD · rev $10.28B vs rev $528.3M
Celanese Corporation (CE) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
CE currently screens at market cap $5.92B. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the CE and FOLD stock pages for the full models.
Not investment advice.